| scholarly article | Q13442814 |
| P356 | DOI | 10.1146/ANNUREV-PATHOL-011110-130235 |
| P953 | full work available at URL | http://arjournals.annualreviews.org/doi/abs/10.1146/annurev-pathol-011110-130235 |
| https://www.annualreviews.org/doi/pdf/10.1146/annurev-pathol-011110-130235 | ||
| P698 | PubMed publication ID | 21090969 |
| P2093 | author name string | Eric R. Fearon | |
| P2860 | cites work | Biochimica et Biophysica Acta | Q864239 |
| Cancer Research | Q326097 | ||
| Hypermutability and mismatch repair deficiency in RER+ tumor cells | Q41508298 | ||
| Activin type 2 receptor restoration in MSI-H colon cancer suppresses growth and enhances migration with activin. | Q41825735 | ||
| Genomic structure and alterations of homeobox gene CDX2 in colorectal carcinomas | Q42013009 | ||
| Clues to the pathogenesis of familial colorectal cancer | Q42622043 | ||
| Altered growth of human colon cancer cell lines disrupted at activated Ki-ras | Q42810367 | ||
| Transformation potential of Ras isoforms correlates with activation of phosphatidylinositol 3-kinase but not ERK. | Q42827942 | ||
| Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome | Q44371959 | ||
| Loss of activin receptor type 2 protein expression in microsatellite unstable colon cancers | Q44779665 | ||
| FBXW7/hCDC4 is a general tumor suppressor in human cancer. | Q45345209 | ||
| Mutant p53 protein localized in the cytoplasm inhibits autophagy | Q46345867 | ||
| Clinical and genetic findings in an Ashkenazi Jewish population with colorectal neoplasms | Q46549856 | ||
| Mechanisms of inactivation of the receptor tyrosine kinase EPHB2 in colorectal tumors. | Q46803723 | ||
| Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype | Q53445992 | ||
| Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC | Q54559294 | ||
| RAS oncogenes: the first 30 years. | Q55036584 | ||
| Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia | Q56418625 | ||
| Hereditary factors in cancer. Study of two large midwestern kindreds | Q56482519 | ||
| Familial Adenomatous Polyposis | Q56486183 | ||
| RAF/RAS oncogenes and mismatch-repair status | Q57281056 | ||
| Genetic mapping of a second locus predisposing to hereditary non–polyposis colon cancer | Q58862199 | ||
| Cytogenetics of colorectal adenocarcinomas | Q68786733 | ||
| Hypomethylation of DNA from benign and malignant human colon neoplasms | Q69381419 | ||
| Hereditary colorectal cancer | Q73088287 | ||
| Loss of IGF2 imprinting: a potential marker of colorectal cancer risk | Q73128690 | ||
| Identification of critical CpG sites for repression of L1 transcription by DNA methylation | Q73378476 | ||
| Mutations of p53 gene in human colorectal cancer: distinct frameshifts among populations | Q73687941 | ||
| Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis | Q22122362 | ||
| Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein | Q24291288 | ||
| Identification of c- MYC as a Target of the APC Pathway | Q24310637 | ||
| The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells | Q24314491 | ||
| Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways | Q24317164 | ||
| Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer | Q24319963 | ||
| Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability | Q24319995 | ||
| Familial colorectal cancer type X: the other half of hereditary nonpolyposis colon cancer syndrome | Q24594612 | ||
| The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores | Q24649374 | ||
| Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers | Q24649562 | ||
| Regulation of autophagy by cytoplasmic p53 | Q24651258 | ||
| Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers | Q24656162 | ||
| Seminars in gastrointestinal disease | Q27714056 | ||
| Stage-specific alterations of the genome, transcriptome, and proteome during colorectal carcinogenesis | Q79252702 | ||
| CpG island methylator phenotype in cancer | Q81080870 | ||
| Frequency of familial colon cancer and hereditary nonpolyposis colorectal cancer (Lynch syndrome) in a large population database | Q81149391 | ||
| Effects of oncogenic p110alpha subunit mutations on the lipid kinase activity of phosphoinositide 3-kinase | Q81314502 | ||
| Novel mutations of the suppressor gene PTEN in colorectal carcinomas stratified by microsatellite instability- and TP53 mutation- status | Q81946858 | ||
| Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases | Q82657420 | ||
| A genetic model for colorectal tumorigenesis | Q27860582 | ||
| The functions of animal microRNAs | Q27860621 | ||
| The genomic landscapes of human breast and colorectal cancers | Q27861078 | ||
| MicroRNA expression profiles classify human cancers | Q28032481 | ||
| High frequency of mutations of the PIK3CA gene in human cancers | Q28131776 | ||
| Lessons from hereditary colorectal cancer | Q28131788 | ||
| Statins and the risk of colorectal cancer | Q28176056 | ||
| Colorectal cancer prevention | Q28212789 | ||
| Genetic instability in human mismatch repair deficient cancers | Q28214754 | ||
| New insights into TGF-beta-Smad signalling | Q28260517 | ||
| Low frequency of AXIN2 mutations and high frequency of MUTYH mutations in patients with multiple polyposis | Q28260891 | ||
| Genetic mapping of a locus predisposing to human colorectal cancer | Q28268634 | ||
| Colorectal cancer and genetic alterations in the Wnt pathway | Q28276998 | ||
| Genetic alterations during colorectal-tumor development | Q28281200 | ||
| Clonal analysis of human colorectal tumors | Q28283169 | ||
| Identification of mismatch repair genes and their role in the development of cancer | Q28288647 | ||
| CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity | Q28294122 | ||
| Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB | Q28508041 | ||
| Blinded by the Light: The Growing Complexity of p53 | Q29547590 | ||
| Cancer statistics, 2009 | Q29547625 | ||
| CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer | Q29614277 | ||
| Phenotypic plasticity and the epigenetics of human disease | Q29614515 | ||
| Gene silencing in cancer in association with promoter hypermethylation | Q29617274 | ||
| Genetic instability in colorectal cancers | Q29618711 | ||
| Microsatellite instability in cancer of the proximal colon | Q29620692 | ||
| Modulation of microRNA processing by p53 | Q29620776 | ||
| Mutations in the APC gene and their implications for protein structure and function | Q30418378 | ||
| LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability | Q33283510 | ||
| Analysis of the association between CIMP and BRAF in colorectal cancer by DNA methylation profiling | Q33520213 | ||
| Colorectal cancer: molecules and populations | Q33652932 | ||
| Population-based family history-specific risks for colorectal cancer: a constellation approach | Q33699254 | ||
| Convergence of hormones, inflammation, and energy-related factors: a novel pathway of cancer etiology | Q33954537 | ||
| Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study | Q34102606 | ||
| Influence of target gene mutations on survival, stage and histology in sporadic microsatellite unstable colon cancers | Q34138113 | ||
| Allelotype of colorectal carcinomas | Q34461209 | ||
| Revving the Throttle on an oncogene: CDK8 takes the driver seat | Q37389726 | ||
| The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. | Q37436205 | ||
| MYC-induced cancer cell energy metabolism and therapeutic opportunities | Q37438881 | ||
| Cytoplasmic functions of the tumour suppressor p53. | Q37466228 | ||
| MicroRNAs, ultraconserved genes and colorectal cancers | Q37508276 | ||
| MicroRNAs in colorectal cancer: translation of molecular biology into clinical application | Q37632608 | ||
| DNA methylation markers in colorectal cancer | Q37687919 | ||
| Genetic instability occurs in the majority of young patients with colorectal cancer | Q38297232 | ||
| Analysis of PTEN, BRAF, and EGFR status in determining benefit from cetuximab therapy in wild-type KRAS metastatic colon cancer. | Q38934630 | ||
| A dual role of p53 in the control of autophagy | Q39964629 | ||
| TCF-4 isoforms absent in TCF-4 mutated MSI-H colorectal cancer cells colocalize with nuclear CtBP and repress TCF-4-mediated transcription | Q40302206 | ||
| DNA demethylation and pericentromeric rearrangements of chromosome 1 | Q41087672 | ||
| Very high risk of cancer in familial Peutz-Jeghers syndrome | Q34512286 | ||
| CDK8 expression in 470 colorectal cancers in relation to beta-catenin activation, other molecular alterations and patient survival. | Q34561921 | ||
| Peutz-Jeghers syndrome: clinicopathology and molecular alterations | Q34570577 | ||
| The role of the APC tumor suppressor in chromosomal instability | Q34596019 | ||
| Microsatellite instability in colorectal cancer-the stable evidence | Q34616565 | ||
| Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene | Q34690901 | ||
| Natural history of untreated colonic polyps. | Q34691452 | ||
| Cancer family “G” revisited: 1895-1970 | Q34701495 | ||
| Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup | Q34728738 | ||
| Beta-catenin hits chromatin: regulation of Wnt target gene activation | Q34967116 | ||
| PTEN hamartoma tumor syndrome: an overview | Q34996547 | ||
| The role of Myc-induced protein synthesis in cancer | Q35014312 | ||
| BRAF mutations in aberrant crypt foci and hyperplastic polyposis | Q35083792 | ||
| Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome | Q35588576 | ||
| Genomic instability and colon cancer | Q35682092 | ||
| Diagnosis and management of dysplasia in patients with inflammatory bowel diseases | Q35787460 | ||
| Genetic conditions associated with intestinal juvenile polyps | Q35841136 | ||
| Risk of colorectal cancer in juvenile polyposis | Q36013971 | ||
| mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer | Q36103305 | ||
| MutYH (MYH) and colorectal cancer | Q36206408 | ||
| Integrative genomics reveals mechanisms of copy number alterations responsible for transcriptional deregulation in colorectal cancer | Q36487126 | ||
| Mutations of TGFbeta signaling molecules in human disease | Q36606635 | ||
| Classification of colorectal cancer based on correlation of clinical, morphological and molecular features | Q36699559 | ||
| The many ways of Wnt in cancer | Q36701583 | ||
| DNA methylation: the nuts and bolts of repression | Q36914335 | ||
| The genetics of hereditary colon cancer | Q36972251 | ||
| The Fbxw7/hCdc4 tumor suppressor in human cancer | Q37187016 | ||
| PTEN and the PI3-kinase pathway in cancer | Q37259680 | ||
| Class I PI3K in oncogenic cellular transformation. | Q37270450 | ||
| APC shuttling to the membrane, nucleus and beyond | Q37291638 | ||
| Myc's broad reach | Q37299032 | ||
| LKB1; linking cell structure and tumor suppression | Q37333592 | ||
| Lynch syndrome and related familial colorectal cancers | Q37357249 | ||
| Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR. | Q37360712 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| colorectal carcinoma | Q25493920 | ||
| P304 | page(s) | 479-507 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Annual Review of Pathology: Mechanisms of Disease | Q15263665 |
| P1476 | title | Molecular genetics of colorectal cancer | |
| Molecular Genetics of Colorectal Cancer | |||
| P478 | volume | 6 |
| Q93018069 | (Pro)renin Receptor Expression Increases throughout the Colorectal Adenoma-Adenocarcinoma Sequence and It Is Associated with Worse Colorectal Cancer Prognosis |
| Q58548750 | A Bioinformatic Profile of Gene Expression of Colorectal Carcinoma Derived Organoids |
| Q60933442 | A C/EBPα-Wnt connection in gut homeostasis and carcinogenesis |
| Q39002395 | A Prospective Study of Smoking and Risk of Synchronous Colorectal Cancers |
| Q57709818 | A bacterial driver–passenger model for colorectal cancer: beyond the usual suspects |
| Q30561752 | A calibrated agent-based computer model of stochastic cell dynamics in normal human colon crypts useful for in silico experiments |
| Q37608528 | A colon cancer-derived mutant of Krüppel-like factor 5 (KLF5) is resistant to degradation by glycogen synthase kinase 3β (GSK3β) and the E3 ubiquitin ligase F-box and WD repeat domain-containing 7α (FBW7α). |
| Q38912247 | A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells |
| Q37620700 | A functional role for Smad7 in sustaining colon cancer cell growth and survival. |
| Q37141208 | A gene browser of colorectal cancer with literature evidence and pre-computed regulatory information to identify key tumor suppressors and oncogenes |
| Q27852431 | A genetic progression model of Braf(V600E)-induced intestinal tumorigenesis reveals targets for therapeutic intervention. |
| Q36959154 | A hot L1 retrotransposon evades somatic repression and initiates human colorectal cancer |
| Q37017721 | A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC. |
| Q39787266 | A network-based analysis of colon cancer splicing changes reveals a tumorigenesis-favoring regulatory pathway emanating from ELK1 |
| Q34737151 | A novel colorectal cancer risk locus at 4q32.2 identified from an international genome-wide association study |
| Q34455992 | A red meat-derived glycan promotes inflammation and cancer progression |
| Q35777548 | A survey of tandem repeat instabilities and associated gene expression changes in 35 colorectal cancers |
| Q64924502 | ANIMAL MODELS FOR COLORECTAL CANCER. |
| Q38041525 | APC and DNA Demethylation in Cell Fate Specification and Intestinal Cancer |
| Q39313634 | APC hypermethylation for early diagnosis of colorectal cancer: a meta-analysis and literature review |
| Q37209158 | APC2 and Axin promote mitotic fidelity by facilitating centrosome separation and cytoskeletal regulation |
| Q30354461 | ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice. |
| Q37056909 | Aberrant Promoter Methylation at CpG Cytosines Induce the Upregulation of the E2F5 Gene in Breast Cancer |
| Q55211165 | Aberrant promoter methylation status is associated with upregulation of the E2F4 gene in breast cancer. |
| Q38631444 | Aberrantly methylated-differentially expressed genes and pathways in colorectal cancer |
| Q36391986 | Abnormal expression of GADD45B in human colorectal carcinoma |
| Q38760598 | Activation of Wnt/β-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell States |
| Q38983986 | Activation of the PI3K/Akt/mTOR/p70S6K pathway is involved in S100A4-induced viability and migration in colorectal cancer cells |
| Q52625681 | Active BRAF-V600E is the key player in generation of a sessile serrated polyp-specific DNA methylation profile. |
| Q35761547 | Adiponectin Gene Polymorphisms are Associated with Increased Risk of Colorectal Cancer |
| Q40771944 | Advanced Proteogenomic Analysis Reveals Multiple Peptide Mutations and Complex Immunoglobulin Peptides in Colon Cancer |
| Q34671136 | Advanced colorectal adenoma related gene expression signature may predict prognostic for colorectal cancer patients with adenoma-carcinoma sequence. |
| Q45711137 | Alterations in the EGFR pathway coincide in colorectal cancer and impact on prognosis |
| Q93226610 | Altered ARID1A expression in colorectal cancer |
| Q35677014 | Altered Interactions between the Gut Microbiome and Colonic Mucosa Precede Polyposis in APCMin/+ Mice |
| Q92135237 | Altered expression of renin-angiotensin system receptors throughout colorectal adenoma-adenocarcinoma sequence |
| Q35313181 | Altered pathways and colorectal cancer prognosis |
| Q40888327 | An AXIN2 Mutant Allele Associated With Predisposition to Colorectal Neoplasia Has Context-Dependent Effects on AXIN2 Protein Function |
| Q38619061 | An Optimal Mean Based Block Robust Feature Extraction Method to Identify Colorectal Cancer Genes with Integrated Data |
| Q92643926 | An enhanced genetic model of colorectal cancer progression history |
| Q91276869 | An immunohistochemical approach to detect oncogenic CTNNB1 mutations in primary neoplastic tissues |
| Q35882267 | An in vivo molecular response analysis of colorectal cancer treated with Astragalus membranaceus extract |
| Q85649650 | An updated meta-analysis of the association between GSTM1 polymorphism and colorectal cancer in Asians |
| Q55387488 | Analysis of potential genes and pathways associated with the colorectal normal mucosa-adenoma-carcinoma sequence. |
| Q27009170 | Animal models of colorectal cancer |
| Q54309791 | Annexin A10 is a marker for the serrated pathway of colorectal carcinoma |
| Q50284827 | Antagonistic Interactions between Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase and Retinoic Acid Receptor Signaling in Colorectal Cancer Cells |
| Q35154305 | Apc and p53 interaction in DNA damage and genomic instability in hepatocytes |
| Q28315014 | Apoptotic effect of novel Schiff based CdCl₂(C₁₄H₂₁N₃O₂) complex is mediated via activation of the mitochondrial pathway in colon cancer cells |
| Q36086105 | Application of Circulating Tumor DNA as a Non-Invasive Tool for Monitoring the Progression of Colorectal Cancer |
| Q38015538 | Application of molecular techniques in the diagnosis, prognosis and management of patients with colorectal cancer: a practical approach |
| Q89221788 | Applications of CRISPR-Cas Enzymes in Cancer Therapeutics and Detection |
| Q84445943 | Aqueous Fraction of Nephelium ramboutan-ake Rind Induces Mitochondrial-Mediated Apoptosis in HT-29 Human Colorectal Adenocarcinoma Cells |
| Q38730064 | Aspirin and colorectal cancer: the promise of precision chemoprevention. |
| Q44561607 | Assessment of the association between hOGG1 C8069G polymorphism and colorectal cancer |
| Q47916683 | Association between NQO1 C609T polymorphism and colorectal cancer risk |
| Q64083358 | Association between TP53 genetic polymorphisms and the methylation and expression of miR-34a, 34b/c in colorectal cancer tissues |
| Q35117711 | Association between appendectomy and subsequent colorectal cancer development: an Asian population study |
| Q40198390 | Association between mutations of critical pathway genes and survival outcomes according to the tumor location in colorectal cancer. |
| Q64064834 | Association of pathway mutation with survival after recurrence in colorectal cancer patients treated with adjuvant fluoropyrimidine and oxaliplatin chemotherapy |
| Q54979116 | Aurora kinase A (AURKA) interaction with Wnt and Ras-MAPK signalling pathways in colorectal cancer. |
| Q39123135 | B-cell epitope peptide vaccination targeting dimer interface of epidermal growth factor receptor (EGFR) |
| Q42353442 | BRAF inhibitor treatment of melanoma causing colonic polyps: An alternative hypothesis |
| Q37608879 | BRAFV600E cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis. |
| Q36675203 | Bcl-2 is a critical mediator of intestinal transformation |
| Q91754859 | Biomarker-guided therapy for colorectal cancer: strength in complexity |
| Q37597668 | Bmi1 is required for tumorigenesis in a mouse model of intestinal cancer |
| Q88170682 | Butyrate Inhibits Indices of Colorectal Carcinogenesis via Enhancing α-Ketoglutarate-Dependent DNA Demethylation of Mismatch Repair Genes |
| Q38966986 | CDC42 inhibition suppresses progression of incipient intestinal tumors |
| Q37714068 | CDKL1 promotes tumor proliferation and invasion in colorectal cancer. |
| Q38911627 | CP-31398 prevents the growth of p53-mutated colorectal cancer cells in vitro and in vivo |
| Q52643886 | CREPT facilitates colorectal cancer growth through inducing Wnt/β-catenin pathway by enhancing p300-mediated β-catenin acetylation |
| Q51025967 | CYP2E1 T7632A and 9-bp insertion polymorphisms and colorectal cancer risk: a meta-analysis based on 4,592 cases and 5,918 controls. |
| Q35756082 | Cancer Biology: A New RING to Wnt Signaling |
| Q36737189 | Cancer Stem Cells in Colorectal Cancer: Genetic and Epigenetic Changes |
| Q38050262 | Cancer syndromes and therapy by stop-codon readthrough |
| Q35034857 | Cancer-predicting gene expression changes in colonic mucosa of Western diet fed Mlh1+/- mice |
| Q36094119 | Canonical Wnt suppressor, Axin2, promotes colon carcinoma oncogenic activity |
| Q36920489 | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance |
| Q35799783 | Capturing the Molecular and Biological Diversity of High-Grade Astrocytoma in Genetically Engineered Mouse Models |
| Q36916409 | Cdk3-promoted epithelial-mesenchymal transition through activating AP-1 is involved in colorectal cancer metastasis |
| Q91564745 | Cell type-dependent differential activation of ERK by oncogenic KRAS in colon cancer and intestinal epithelium |
| Q28079969 | Changes in cellular mechanical properties during onset or progression of colorectal cancer |
| Q50195553 | Characterization of Cancer Stem Cells in Colon Adenocarcinoma Metastasis to the Liver |
| Q24318881 | Charting the molecular links between driver and susceptibility genes in colorectal cancer |
| Q34110442 | Checkpoint Signaling, Base Excision Repair, and PARP Promote Survival of Colon Cancer Cells Treated with 5-Fluorodeoxyuridine but Not 5-Fluorouracil |
| Q37109620 | Chemopreventive activity of GEN-27, a genistein derivative, in colitis-associated cancer is mediated by p65-CDX2-β-catenin axis |
| Q38059925 | Chromothripsis: chromosomes in crisis |
| Q26801596 | Chronic inflammation and the development of malignancy in the GI tract |
| Q97587502 | CircAGFG1 drives metastasis and stemness in colorectal cancer by modulating YY1/CTNNB1 |
| Q47630611 | Circadian gene hCLOCK contributes to progression of colorectal carcinoma and is directly regulated by tumor‑suppressive microRNA‑124. |
| Q35387747 | Circadian gene hClock enhances proliferation and inhibits apoptosis of human colorectal carcinoma cells in vitro and in vivo |
| Q35183062 | Clinical Response to Sorafenib in a Patient with Metastatic Colorectal Cancer and FLT3 Amplification |
| Q34378719 | Clinical application of genetics in management of colorectal cancer |
| Q37266384 | Clinical applications of next-generation sequencing in colorectal cancers |
| Q47682948 | Clinical performance evaluation of the Idylla NRAS-BRAF mutation test on retrospectively collected formalin-fixed paraffin-embedded colorectal cancer tissue |
| Q37086263 | Clinicopathologic distribution of KRAS and BRAF mutations in a Chinese population with colorectal cancer precursor lesions |
| Q33842013 | Co-occurrence of driver and passenger bacteria in human colorectal cancer |
| Q57100445 | Collaborating genomic, transcriptomic and microbiomic alterations lead to canine extreme intestinal polyposis |
| Q27853014 | Colon cancer-derived oncogenic EGFR G724S mutant identified by whole genome sequence analysis is dependent on asymmetric dimerization and sensitive to cetuximab |
| Q52655145 | Colon cancers carrying BRAF V600E and β-catenin T41A activating mutations are resistant to numerous common anticancer drugs |
| Q38652194 | Colorectal Cancer Subtypes: Developmental Origin and Microenvironmental Regulation |
| Q57191694 | Colorectal cancer |
| Q36053988 | Colorectal cancer DNA methylation patterns from patients in Manaus, Brazil |
| Q37399066 | Colorectal cancer and the KIR genes in the human genome: A meta-analysis |
| Q34207776 | Colorectal cancer with liver metastases: neoadjuvant chemotherapy, surgical resection first or palliation alone? |
| Q55411157 | Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells. |
| Q34997425 | Colorectal cancers from distinct ancestral populations show variations in BRAF mutation frequency |
| Q58737393 | Colorectal carcinogenesis: Insights into the cell death and signal transduction pathways: A review |
| Q35579056 | Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages |
| Q39036665 | Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomas |
| Q58588233 | Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2 |
| Q35135763 | Commensal bacteria drive endogenous transformation and tumour stem cell marker expression through a bystander effect |
| Q35990690 | Comparative analysis of copy number variations in ulcerative colitis associated and sporadic colorectal neoplasia. |
| Q64970890 | Comparison of Microbiota in Patients Treated by Surgery or Chemotherapy by 16S rRNA Sequencing Reveals Potential Biomarkers for Colorectal Cancer Therapy. |
| Q41230971 | Comparison of biomarker expression between proximal and distal colorectal adenomas: The Tennessee-Indiana Adenoma Recurrence Study |
| Q92392618 | Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumors |
| Q50966522 | Comparison of the performance of guaiac‐based and two immunochemical fecal occult blood tests for identifying advanced colorectal neoplasia in Taiwan |
| Q64253706 | Complex karyotype in myelodysplastic syndromes: Diagnostic procedure and prognostic susceptibility |
| Q61965595 | Comprehensive evaluation of coding region point mutations in microsatellite‐unstable colorectal cancer |
| Q24630415 | Comprehensive molecular characterization of human colon and rectal cancer |
| Q89838002 | Conformation-specific inhibitors of activated Ras GTPases reveal limited Ras dependency of patient-derived cancer organoids |
| Q39066439 | Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer |
| Q35660195 | Constructing lncRNA functional similarity network based on lncRNA-disease associations and disease semantic similarity |
| Q36027763 | Construction and Experimental Validation of a Petri Net Model of Wnt/β-Catenin Signaling. |
| Q36292548 | Construction of a multiplex mutation hot spot PCR panel: the first step towards colorectal cancer genotyping on the GS Junior platform |
| Q41334598 | Contribution of galectin-1, a glycan-binding protein, to gastrointestinal tumor progression |
| Q35643491 | Correlation between smoking history and molecular pathways in sporadic colorectal cancer: a meta-analysis. |
| Q36183202 | Correlation of NGX6 expression with clinicopathologic features and prognosis in colon cancer |
| Q37702124 | Cortactin promotes colorectal cancer cell proliferation by activating the EGFR-MAPK pathway |
| Q90158360 | Cost-effectiveness Evaluation of Targeted Surgical and Endoscopic Therapies for Early Colorectal Adenocarcinoma Based on Biomarker Profiles |
| Q43527311 | Cullin 4B is a novel prognostic marker that correlates with colon cancer progression and pathogenesis |
| Q58715258 | Curcumin mediates polyamine metabolism and sensitizes gastrointestinal cancer cells to antitumor polyamine-targeted therapies |
| Q37697538 | Current and future molecular diagnostics in colorectal cancer and colorectal adenoma. |
| Q26747795 | Current status and perspectives in atomic force microscopy-based identification of cellular transformation |
| Q36210955 | DDX3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer |
| Q37059820 | DNA Hypomethylation Contributes to Genomic Instability and Intestinal Cancer Initiation |
| Q54382592 | DNA content analysis of colorectal cancer defines a distinct 'microsatellite and chromosome stable' group but does not predict response to radiotherapy |
| Q30837199 | DNA copy number changes define spatial patterns of heterogeneity in colorectal cancer. |
| Q92017414 | DNA methylation instability by BRAF-mediated TET silencing and lifestyle-exposure divides colon cancer pathways |
| Q31813071 | DUSP10 regulates intestinal epithelial cell growth and colorectal tumorigenesis |
| Q93007741 | Dancing from bottoms up - Roles of the POZ-ZF transcription factor Kaiso in Cancer |
| Q28083490 | Death-associated protein kinase: A molecule with functional antagonistic duality and a potential role in inflammatory bowel disease (Review) |
| Q35048299 | Deciphering genomic alterations in colorectal cancer through transcriptional subtype-based network analysis |
| Q47164137 | Degree of Tissue Differentiation Dictates Susceptibility to BRAF-Driven Colorectal Cancer |
| Q38572102 | Deoxyribonucleotide metabolism, mutagenesis and cancer |
| Q40627933 | Deregulation of STING Signaling in Colorectal Carcinoma Constrains DNA Damage Responses and Correlates With Tumorigenesis |
| Q39085740 | Determinants of metastatic competency in colorectal cancer |
| Q38049051 | Developmental pathways in colon cancer: crosstalk between WNT, BMP, Hedgehog and Notch |
| Q59350458 | Diagnostic Potential and Interactive Dynamics of the Colorectal Cancer Virome |
| Q41618379 | Difference in expression of two neurokinin-1 receptors in adenoma and carcinoma from patients that underwent radical surgery for colorectal carcinoma |
| Q41378204 | Differential abundance of CK1α provides selectivity for pharmacological CK1α activators to target WNT-dependent tumors |
| Q37561628 | Differential expression of carbohydrate antigen 19-9 in human colorectal cancer: A comparison with colon and rectal cancers |
| Q36018367 | Dissecting characteristics and dynamics of differentially expressed proteins during multistage carcinogenesis of human colorectal cancer |
| Q35652713 | Distinct Clinicopathological Patterns of Mismatch Repair Status in Colorectal Cancer Stratified by KRAS Mutations |
| Q33699404 | Diverse expression patterns and tumorigenic role of neurotensin signaling components in colorectal cancer cells |
| Q33911191 | Downregulation of GRHL2 inhibits the proliferation of colorectal cancer cells by targeting ZEB1 |
| Q98386365 | Downregulation of microRNA-126 is inversely correlated with insulin receptor substrate-1 protein expression in colorectal cancer and is associated with advanced stages of disease |
| Q64269180 | Drug Sensitivity Screening and Targeted Pathway Analysis Reveal a Multi-Driver Proliferative Mechanism and Suggest a Strategy of Combination Targeted Therapy for Colorectal Cancer Cells |
| Q33613855 | Dynamic microbe and molecule networks in a mouse model of colitis-associated colorectal cancer |
| Q37472937 | E2A predicts prognosis of colorectal cancer patients and regulates cancer cell growth by targeting miR-320a |
| Q37194925 | ER stress transcription factor Xbp1 suppresses intestinal tumorigenesis and directs intestinal stem cells |
| Q39345541 | Early detection: the impact of genomics |
| Q37288375 | Effect of API-1 and FR180204 on cell proliferation and apoptosis in human DLD-1 and LoVo colorectal cancer cells |
| Q35711107 | Effect of Maternal and Post-Weaning Folate Supply on Gene-Specific DNA Methylation in the Small Intestine of Weaning and Adult Apc+/Min and Wild Type Mice |
| Q92533188 | Effects of obesity and weight loss on mitochondrial structure and function and implications for colorectal cancer risk |
| Q34621479 | Efficient recovery of proteins from multiple source samples after TRIzol(®) or TRIzol(®)LS RNA extraction and long-term storage. |
| Q91838765 | Elevating H3K27me3 level sensitizes colorectal cancer to oxaliplatin |
| Q26829126 | Emerging role of the β-catenin-PPARγ axis in the pathogenesis of colorectal cancer |
| Q51452289 | Endoluminal high-resolution MR imaging protocol for colon walls analysis in a mouse model of colitis |
| Q89619465 | Enterotoxigenic Bacteroides fragilis infection exacerbates tumorigenesis in AOM/DSS mouse model |
| Q28084849 | Epigenetic regulation of the intestinal epithelium |
| Q22252606 | Epigenetics Offer New Horizons for Colorectal Cancer Prevention |
| Q36081553 | Epigenetics and colorectal cancer |
| Q37061792 | Epigenetics and colorectal cancer pathogenesis |
| Q40357382 | Epigenomic landscape of 5-hydroxymethylcytosine reveals its transcriptional regulation of lncRNAs in colorectal cancer. |
| Q39107166 | Epithelial Hypoxia-Inducible Factor 2α Facilitates the Progression of Colon Tumors through Recruiting Neutrophils |
| Q90129976 | Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis |
| Q38763748 | Epithelial-to-mesenchymal transition transcription factors in cancer-associated fibroblasts |
| Q34704942 | Establishment of genetically diverse patient-derived xenografts of colorectal cancer. |
| Q91618178 | Evaluation of colorectal cancer subtypes and cell lines using deep learning |
| Q46016448 | Evolution of genetic instability in heterogeneous tumors. |
| Q37702251 | Evolutionary biologic changes of gut microbiota in an 'adenoma-carcinoma sequence' mouse colorectal cancer model induced by 1, 2-Dimethylhydrazine |
| Q36097337 | Exome sequencing of a colorectal cancer family reveals shared mutation pattern and predisposition circuitry along tumor pathways |
| Q38683093 | Expending Role of Microsatellite Instability in Diagnosis and Treatment of Colorectal Cancers. |
| Q97539272 | Exploring and modelling colon cancer inter-tumour heterogeneity: opportunities and challenges |
| Q23911034 | Exposure to carbon nanotubes leads to changes in the cellular biomechanics |
| Q37192986 | Expression Pattern and Clinicopathological Relevance of the Indoleamine 2,3-Dioxygenase 1/Tryptophan 2,3-Dioxygenase Protein in Colorectal Cancer. |
| Q37712679 | Expression Status of UBE2Q2 in Colorectal Primary Tumors and Cell Lines |
| Q64885531 | Expression and Localization of Cathepsins B, D and G in Cancer Stem Cells in Liver Metastasis From Colon Adenocarcinoma. |
| Q37106692 | Expression of MCRS1 and MCRS2 and their correlation with serum carcinoembryonic antigen in colorectal cancer |
| Q36297343 | Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF. |
| Q39662667 | Expression of mitochondrial genes MT-ND1, MT-ND6, MT-CYB, MT-COI, MT-ATP6, and 12S/MT-RNR1 in colorectal adenopolyps. |
| Q36321648 | Extensive quantitative remodeling of the proteome between normal colon tissue and adenocarcinoma. |
| Q92713830 | FGF14 Functions as a Tumor Suppressor through Inhibiting PI3K/AKT/mTOR Pathway in Colorectal Cancer |
| Q38205339 | Familial colorectal cancer type X: genetic profiles and phenotypic features. |
| Q89766936 | Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis |
| Q90208541 | Feedback analysis identifies a combination target for overcoming adaptive resistance to targeted cancer therapy |
| Q92127401 | Flavopereirine Suppresses the Growth of Colorectal Cancer Cells through P53 Signaling Dependence |
| Q38232753 | Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis |
| Q38831347 | Focusing the Spotlight on the Zebrafish Intestine to Illuminate Mechanisms of Colorectal Cancer |
| Q34372544 | Forced Expression of miR-143 Represses ERK5/c-Myc and p68/p72 Signaling in Concert with miR-145 in Gut Tumors of ApcMin Mice |
| Q34515894 | Frequent alteration of the tumor suppressor gene APC in sporadic canine colorectal tumors |
| Q50199383 | From the Cover: PhIP/DSS-Induced Colon Carcinogenesis in CYP1A-Humanized Mice and the Possible Role of Lgr5+ Stem Cells |
| Q38786707 | From tumour heterogeneity to advances in precision treatment of colorectal cancer |
| Q43241085 | Functional and protein‑protein interaction network analysis of colorectal cancer induced by ulcerative colitis |
| Q34357186 | Functional annotation of colon cancer risk SNPs |
| Q92971616 | Functional characterization of CNOT3 variants identified in familial adenomatous polyposis adenomas |
| Q35273347 | Functional repair of p53 mutation in colorectal cancer cells using trans-splicing |
| Q50026061 | Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer |
| Q36292186 | GSTM1 polymorphism contribute to colorectal cancer in Asian populations: a prospective meta-analysis |
| Q37384881 | Gamma-tocopherol attenuates moderate but not severe colitis and suppresses moderate colitis-promoted colon tumorigenesis in mice |
| Q37716976 | Gastrointestinal malignancy and the microbiome. |
| Q94322174 | Gene Expression Analysis of Sporadic Early-Onset Rectal Adenocarcinoma |
| Q47099108 | Gene expression profile comparison between colorectal cancer and adjacent normal tissues |
| Q42775534 | Gene-Diet Interactions on Colorectal Cancer Risk |
| Q37369513 | Generation of an inducible colon-specific Cre enzyme mouse line for colon cancer research |
| Q37230991 | Genetic Diversity of Pancreatic Ductal Adenocarcinoma and Opportunities for Precision Medicine |
| Q35815688 | Genetic Manipulation of Homologous Recombination In Vivo Attenuates Intestinal Tumorigenesis |
| Q35091509 | Genetic analysis of colon tumors induced by a dietary carcinogen PhIP in CYP1A humanized mice: Identification of mutation of β-catenin/Ctnnb1 as the driver gene for the carcinogenesis |
| Q35989027 | Genetic and Diet-Induced Obesity Increased Intestinal Tumorigenesis in the Double Mutant Mouse Model Multiple Intestinal Neoplasia X Obese via Disturbed Glucose Regulation and Inflammation |
| Q37730129 | Genetic dissection of colorectal cancer progression by orthotopic transplantation of engineered cancer organoids |
| Q40228878 | Genetic heterogeneity in synchronous colorectal cancers impacts genotyping approaches and therapeutic strategies |
| Q34832690 | Genetic pathways, prevention, and treatment of sporadic colorectal cancer |
| Q38191462 | Genetic unraveling of colorectal cancer |
| Q92662598 | Genetically Engineered Pigs to Study Cancer |
| Q50107614 | Genetically engineered pigs as models for human disease |
| Q28084346 | Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer |
| Q28082721 | Genetics of colorectal cancer |
| Q37445217 | Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips. |
| Q53228400 | Genome-wide linkage analysis and tumoral characterization reveal heterogeneity in familial colorectal cancer type X. |
| Q37326689 | Genome-wide multi-omics profiling of colorectal cancer identifies immune determinants strongly associated with relapse |
| Q37087002 | Genomic Landscape of Colorectal Mucosa and Adenomas |
| Q64963172 | Genomic clustering of fitness-affecting mutations favors the evolution of chromosomal instability. |
| Q34657586 | Genomic era diagnosis and management of hereditary and sporadic colon cancer. |
| Q34560110 | Genomic homeostasis is dysregulated in favour of apoptosis in the colonic epithelium of the azoxymethane treated rat. |
| Q37687487 | Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients |
| Q38074617 | Genomics and epigenomics of colorectal cancer |
| Q39967039 | Genotyping of colorectal cancer for cancer precision medicine: Results from the IPH Center for Molecular Pathology |
| Q36677253 | Get the Fat Out! |
| Q37699199 | Gli1 promotes colorectal cancer metastasis in a Foxm1-dependent manner by activating EMT and PI3K-AKT signaling |
| Q39395261 | Global methylation profiling to identify epigenetic signature of gallbladder cancer and gallstone disease. |
| Q43878989 | Glutathione S-transferase M1 polymorphism and colorectal cancer risk in Chinese population |
| Q57980063 | Group I Paks are essential for epithelial- mesenchymal transition in an Apc-driven model of colorectal cancer |
| Q39120155 | Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer |
| Q28074181 | Guanylyl cyclase C signaling axis and colon cancer prevention |
| Q26775402 | Gut Microbiota and Colorectal Cancer |
| Q35172970 | Gut microbiome and colorectal adenomas |
| Q92358237 | Gut microbiome associated with APC gene mutation in patients with intestinal adenomatous polyps |
| Q91641742 | Gut microbiome identifies risk for colorectal polyps |
| Q37584313 | HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker |
| Q30847630 | HMGA1 amplifies Wnt signalling and expands the intestinal stem cell compartment and Paneth cell niche |
| Q34140330 | HMGA1 induces intestinal polyposis in transgenic mice and drives tumor progression and stem cell properties in colon cancer cells |
| Q37447969 | High FOXRED1 expression predicted good prognosis of colorectal cancer |
| Q36694384 | High expression of Fatty Acid-Binding Protein 5 promotes cell growth and metastatic potential of colorectal cancer cells |
| Q36184195 | High-Throughput Screening Strategies for Targeted Identification of Therapeutic Compounds in Colorectal Cancer |
| Q42720297 | High-throughput sequencing to identify miRNA biomarkers in colorectal cancer patients |
| Q36717750 | Highly sensitive, non-invasive detection of colorectal cancer mutations using single molecule, third generation sequencing |
| Q47927828 | Histone methyltransferase SETD2 modulates alternative splicing to inhibit intestinal tumorigenesis |
| Q50850992 | Hsp70 exerts oncogenic activity in the Apc mutant Min mouse model |
| Q41678975 | Hypoxia-inducible factors: a central link between inflammation and cancer |
| Q34603915 | ICAD deficiency in human colon cancer and predisposition to colon tumorigenesis: linkage to apoptosis resistance and genomic instability |
| Q50041873 | IKKα is required in the intestinal epithelial cells for tumour stemness. |
| Q53236646 | IKKα promotes intestinal tumorigenesis by limiting recruitment of M1-like polarized myeloid cells |
| Q35993139 | ITF-2B protein levels are correlated with favorable prognosis in patients with colorectal carcinomas. |
| Q34354515 | Identification of 33 candidate oncogenes by screening for base-specific mutations. |
| Q36121608 | Identification of Aging-Associated Gene Expression Signatures That Precede Intestinal Tumorigenesis. |
| Q55027358 | Identification of copy number alterations in colon cancer from analysis of amplicon-based next generation sequencing data. |
| Q55002474 | Identification of different mutational profiles in cancers arising in specific colon segments by next generation sequencing. |
| Q92154743 | Identification of differentially expressed genes regulated by methylation in colon cancer based on bioinformatics analysis |
| Q44032588 | Identification of hub genes, key miRNAs and potential molecular mechanisms of colorectal cancer |
| Q34977426 | Identification of novel mutations by exome sequencing in African American colorectal cancer patients |
| Q53827639 | Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome. |
| Q36492931 | Immunohistochemistry and microsatellite instability analysis in molecular subtyping of colorectal carcinoma based on mismatch repair competency |
| Q84238463 | Immunostaining in the context of loss mismatch repair function: interpretive confounders and cautionary tales! |
| Q90113851 | Immunotherapy, Inflammation and Colorectal Cancer |
| Q64105079 | Impact of the gut microbiome on the genome and epigenome of colon epithelial cells: contributions to colorectal cancer development |
| Q35037258 | Implications of epithelial-mesenchymal plasticity for heterogeneity in colorectal cancer. |
| Q36934236 | In vitro organoid culture of primary mouse colon tumors |
| Q35007556 | In vivo molecular mapping of the tumor microenvironment in an azoxymethane-treated mouse model of colon carcinogenesis |
| Q39188239 | In-depth characterization of the secretome of colorectal cancer metastatic cells identifies key proteins in cell adhesion, migration, and invasion. |
| Q39162939 | Inactivation of TGF-β signaling and loss of PTEN cooperate to induce colon cancer in vivo |
| Q64891149 | Increased EZH2 expression during the adenoma-carcinoma sequence in colorectal cancer. |
| Q49925787 | Increased colon cancer risk after severe Salmonella infection |
| Q36761921 | Increased expression of Solute carrier family 12 member 5 via gene amplification contributes to tumour progression and metastasis and associates with poor survival in colorectal cancer |
| Q38860405 | Increased incidence of FBXW7 and POLE proofreading domain mutations in young adult colorectal cancers. |
| Q92632779 | Infection with genotoxin-producing Salmonella enterica synergises with loss of the tumour suppressor APC in promoting genomic instability via the PI3K pathway in colonic epithelial cells |
| Q60511100 | Inflammation and Colorectal Cancer |
| Q42094255 | Influence of miRNA-106b and miRNA-135a on butyrate-regulated expression of p21 and Cyclin D2 in human colon adenoma cells |
| Q41612495 | Inhibition and deficiency of the immunoproteasome subunit LMP7 suppress the development and progression of colorectal carcinoma in mice |
| Q30276647 | Integrated genomic analysis of colorectal cancer progression reveals activation of EGFR through demethylation of the EREG promoter |
| Q35561695 | Integrating contextual miRNA and protein signatures for diagnostic and treatment decisions in cancer |
| Q92361660 | Integrative Gene Expression Profiling Analysis to Investigate Potential Prognostic Biomarkers for Colorectal Cancer |
| Q93081119 | Intercellular Transfer of Oncogenic KRAS via Tunneling Nanotubes Introduces Intracellular Mutational Heterogeneity in Colon Cancer Cells |
| Q36065268 | Interleukin-1 Receptor Type 2 Acts with c-Fos to Enhance the Expression of Interleukin-6 and Vascular Endothelial Growth Factor A in Colon Cancer Cells and Induce Angiogenesis |
| Q59351894 | Interleukin-33 and ST2 Signaling in Tumor Microenvironment |
| Q34989590 | Interplay between DNA repair and inflammation, and the link to cancer |
| Q37083757 | Intestinal Iron Homeostasis and Colon Tumorigenesis |
| Q39365117 | Intestinal carcinogenesis: IKK can go all the way. |
| Q57169731 | Intestinal microbiota: a novel perspective in colorectal cancer biotherapeutics |
| Q24307391 | Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties |
| Q39139446 | Intra-tumor heterogeneity from a cancer stem cell perspective. |
| Q58053534 | Intrinsic cancer subtypes-next steps into personalized medicine |
| Q34995814 | Investigation of 3-aryl-pyrimido[5,4-e][1,2,4]triazine-5,7-diones as small molecule antagonists of β-catenin/TCF transcription |
| Q38949705 | Iro/IRX transcription factors negatively regulate Dpp/TGF-β pathway activity during intestinal tumorigenesis |
| Q38708005 | K-ras Mutations as the Earliest Driving Force in a Subset of Colorectal Carcinomas |
| Q38765961 | KSR1 and EPHB4 Regulate Myc and PGC1β To Promote Survival of Human Colon Tumors |
| Q43481817 | Knockdown of HOXA-AS2 suppresses proliferation and induces apoptosis in colorectal cancer |
| Q35635465 | LIN28 cooperates with WNT signaling to drive invasive intestinal and colorectal adenocarcinoma in mice and humans |
| Q36414307 | LINE-1 hypomethylation in normal colon mucosa is associated with poor survival in Chinese patients with sporadic colon cancer. |
| Q37363897 | LMO2 attenuates tumor growth by targeting the Wnt signaling pathway in breast and colorectal cancer |
| Q30316110 | LRH-1 drives colon cancer cell growth by repressing the expression of the CDKN1A gene in a p53-dependent manner |
| Q34371544 | LSF expression and its prognostic implication in colorectal cancer |
| Q37282490 | Less frequently mutated genes in colorectal cancer: evidences from next-generation sequencing of 653 routine cases |
| Q38940251 | Lhx3 is required to maintain cancer cell development of high-grade oligodendroglioma |
| Q36991078 | Lineage tracing reveals multipotent stem cells maintain human adenomas and the pattern of clonal expansion in tumor evolution. |
| Q35698851 | Lipidoid Nanoparticles for siRNA Delivery to the Intestinal Epithelium: In Vitro Investigations in a Caco-2 Model |
| Q35247201 | Lithium chloride induces mesenchymal‑to‑epithelial reverting transition in primary colon cancer cell cultures. |
| Q47729757 | Logarithmic expansion of LGR5+ cells in human colorectal cancer. |
| Q89495845 | Long non-coding RNA LINC00707 acts as a competing endogenous RNA to enhance cell proliferation in colorectal cancer |
| Q42314709 | Long non-coding RNA SPRY4-IT1 pormotes colorectal cancer metastasis by regulate epithelial-mesenchymal transition |
| Q37706687 | Long non-coding RNA growth arrest specific transcript 5 acts as a tumour suppressor in colorectal cancer by inhibiting interleukin-10 and vascular endothelial growth factor expression |
| Q47138075 | Long non-coding RNAs in Colorectal Cancer: Progression and Future Directions |
| Q64235041 | Long noncoding RNA GIHCG induces cancer progression and chemoresistance and indicates poor prognosis in colorectal cancer |
| Q47106149 | Long noncoding RNA XIST is a prognostic factor in colorectal cancer and inhibits 5-fluorouracil-induced cell cytotoxicity through promoting thymidylate synthase expression |
| Q55424846 | Long noncoding RNA lnc-sox5 modulates CRC tumorigenesis by unbalancing tumor microenvironment. |
| Q36170646 | Long-Range Signaling in MutS and MSH Homologs via Switching of Dynamic Communication Pathways |
| Q40492521 | Long-range epigenetic silencing of chromosome 5q31 protocadherins is involved in early and late stages of colorectal tumorigenesis through modulation of oncogenic pathways. |
| Q42136714 | Loss of HLTF function promotes intestinal carcinogenesis |
| Q35959727 | Loss of Heterozygosity at the Glutathione Peroxidase 1 Locus Is Not an Early Event in Colon Carcinogenesis |
| Q86924304 | Loss of NF2/Merlin expression in advanced sporadic colorectal cancer |
| Q42718487 | Loss of the polycomb mark from bivalent promoters leads to activation of cancer-promoting genes in colorectal tumors |
| Q64245050 | MEK Inhibition Induces Canonical WNT Signaling through YAP in Mutated HCT-15 Cells, and a Cancer Preventive FOXO3/FOXM1 Ratio in Combination with TNKS Inhibition |
| Q36447499 | ML264, A Novel Small-Molecule Compound That Potently Inhibits Growth of Colorectal Cancer |
| Q35931767 | MUC1-C activates the TAK1 inflammatory pathway in colon cancer |
| Q37164549 | MUC4 is negatively regulated through the Wnt/β-catenin pathway via the Notch effector Hath1 in colorectal cancer |
| Q35758028 | MYBL2 is an independent prognostic marker that has tumor-promoting functions in colorectal cancer. |
| Q26740310 | Manipulation of DNA Repair Proficiency in Mouse Models of Colorectal Cancer |
| Q64118815 | Marine omega-3 fatty acid intake and survival of stage III colon cancer according to tumor molecular markers in NCCTG Phase III trial N0147 (Alliance) |
| Q56530637 | Matrix metalloproteinase 9 expression and prognosis in colorectal cancer: a meta-analysis |
| Q64955692 | Mechanism of Apoptosis Induced by Curcumin in Colorectal Cancer. |
| Q35145340 | Membrane protein CNNM4-dependent Mg2+ efflux suppresses tumor progression |
| Q35006439 | Meta-analysis of the association between APC promoter methylation and colorectal cancer |
| Q90633229 | Metaproteomics characterizes human gut microbiome function in colorectal cancer |
| Q37495759 | Metformin: a potential therapeutic agent for recurrent colon cancer |
| Q55072444 | Methylation and Gene Expression of BCAT1 and IKZF1 in Colorectal Cancer Tissues. |
| Q35871204 | Methylation of Werner syndrome protein is associated with the occurrence and development of invasive meningioma via the regulation of Myc and p53 expression |
| Q90062154 | MicroRNA Biogenesis Pathway Genes Are Deregulated in Colorectal Cancer |
| Q34538870 | MicroRNA Methylation in Colorectal Cancer |
| Q42398055 | MicroRNA biomarkers predicting risk, initiation and progression of colorectal cancer |
| Q36901851 | MicroRNA polymorphisms and risk of colorectal cancer |
| Q34282551 | MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer |
| Q38774242 | MicroRNA-92a Promotes Colorectal Cancer Cell Growth and Migration by Inhibiting KLF4. |
| Q90292677 | Microbiota Profile and Impact of Fusobacterium nucleatum in Colorectal Cancer Patients of Barretos Cancer Hospital |
| Q27028132 | Microbiota impact on the epigenetic regulation of colorectal cancer |
| Q42281581 | Micromanaging the classification of colon cancer: the role of the microRNAome. |
| Q37269648 | Microsatellite instability and loss of heterozygosity detected in middle-aged patients with sporadic colon cancer: A retrospective study. |
| Q30378082 | Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesis |
| Q51116841 | Mismatch repair deficient-crypts in non-neoplastic colonic mucosa in Lynch syndrome: insights from an illustrative case |
| Q84301243 | Missense Mutations in MLH1, MSH2, KRAS, and APC Genes in Colorectal Cancer Patients in Malaysia |
| Q55206405 | Mlh1 deficiency in normal mouse colon mucosa associates with chromosomally unstable colon cancer. |
| Q52423411 | Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids |
| Q43212807 | Modelling the evolution of genetic instability during tumour progression |
| Q41037621 | Molecular Characterization of Somatic Alterations in Dukes' B and C Colorectal Cancers by Targeted Sequencing |
| Q38947671 | Molecular Diagnostic Applications in Colorectal Cancer. |
| Q36836733 | Molecular Dissection of Microsatellite Instable Colorectal Cancer |
| Q35977849 | Molecular Events in Primary and Metastatic Colorectal Carcinoma: A Review |
| Q26747329 | Molecular Subtypes and Personalized Therapy in Metastatic Colorectal Cancer |
| Q49912428 | Molecular characterization of colorectal adenomas with and without malignancy reveals distinguishing genome, transcriptome and methylome alterations |
| Q39238579 | Molecular endoscopy for targeted imaging in the digestive tract |
| Q37585385 | Molecular markers of carcinogenesis for risk stratification of individuals with colorectal polyps: a case-control study |
| Q36159222 | Molecular mechanism of adenomatous polyposis coli-induced blockade of base excision repair pathway in colorectal carcinogenesis |
| Q38211357 | Molecular mechanisms of oncogene-induced inflammation and inflammation-sustained oncogene activation in gastrointestinal tumors: an under-appreciated symbiotic relationship |
| Q36545430 | Molecular pathological epidemiology of colorectal cancer in Chinese patients with KRAS and BRAF mutations |
| Q38953543 | Molecular pathways driving disease-specific alterations of intestinal epithelial cells |
| Q41091941 | Molecular profiling of metastatic colorectal tumors using next-generation sequencing: a single-institution experience |
| Q39235977 | Molecular subtypes in cancers of the gastrointestinal tract |
| Q42425332 | Molecular subtyping of colorectal cancer: time to explore both intertumoral and intratumoral heterogeneity to evaluate patient outcome |
| Q26774627 | Mouse models for the discovery of colorectal cancer driver genes |
| Q27008537 | Mouse models of cancer: Sleeping Beauty transposons for insertional mutagenesis screens and reverse genetic studies |
| Q28081871 | Mouse models of colorectal cancer as preclinical models |
| Q26785563 | Mouse models of intestinal cancer |
| Q37238133 | Mucins and Wnt/β-catenin signaling in gastrointestinal cancers: an unholy nexus |
| Q35871650 | Multi-Scale Genomic, Transcriptomic and Proteomic Analysis of Colorectal Cancer Cell Lines to Identify Novel Biomarkers |
| Q34434094 | MultiNotch MS3 enables accurate, sensitive, and multiplexed detection of differential expression across cancer cell line proteomes. |
| Q28547426 | Multidrug Resistance-Associated Protein 2 Expression Is Upregulated by Adenosine 5'-Triphosphate in Colorectal Cancer Cells and Enhances Their Survival to Chemotherapeutic Drugs |
| Q36541309 | Multispectral Endoscopic Imaging of Colorectal Dysplasia In Vivo |
| Q100633769 | Multivalent tumor suppressor adenomatous polyposis coli promotes Axin biomolecular condensate formation and efficient β-catenin degradation |
| Q93367358 | Mutant p53 in colon cancer |
| Q36852678 | Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer. |
| Q89550768 | Mutation Analysis of Colorectal and Gastric Carcinomas Originating from Adenomas: Insights into Genomic Evolution Associated with Malignant Progression |
| Q36526325 | Mutation analysis of 13 driver genes of colorectal cancer-related pathways in Taiwanese patients |
| Q34619293 | Mutational analysis of genes coding for cell surface proteins in colorectal cancer cell lines reveal novel altered pathways, druggable mutations and mutated epitopes for targeted therapy |
| Q37969849 | Mutations and epimutations in the origin of cancer |
| Q34982562 | Mutations in POLE and survival of colorectal cancer patients--link to disease stage and treatment |
| Q33905741 | Mutations of C-reactive protein (CRP) -286 SNP, APC and p53 in colorectal cancer: implication for a CRP-Wnt crosstalk |
| Q37225530 | Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients |
| Q35574969 | Mutual reinforcement of inflammation and carcinogenesis by the Helicobacter pylori CagA oncoprotein |
| Q50575449 | NOD2 Genetic Variants Predispose One of Two Familial Adenomatous Polyposis Siblings to Pouchitis Through Microbiome Dysbiosis |
| Q41342397 | NSC30049 inhibits Chk1 pathway in 5-FU-resistant CRC bulk and stem cell populations. |
| Q37247510 | Nanoproteomic analysis of extracellular receptor kinase-1/2 post-translational activation in microdissected human hyperplastic colon lesions |
| Q52579667 | Nardilysin controls intestinal tumorigenesis through HDAC1/p53-dependent transcriptional regulation. |
| Q90503326 | Neutrophils Restrict Tumor-Associated Microbiota to Reduce Growth and Invasion of Colon Tumors in Mice |
| Q33731804 | New frontiers in the treatment of colorectal cancer: Autophagy and the unfolded protein response as promising targets |
| Q53283058 | Non-serrated precursor lesions of colorectal tumours |
| Q33600442 | Notch as a Driver of Gastric Epithelial Cell Proliferation |
| Q36562344 | Novel insights into Notum and glypicans regulation in colorectal cancer |
| Q52640415 | Novel putative drivers revealed by targeted exome sequencing of advanced solid tumors. |
| Q37085942 | Novel role of STRAP in progression and metastasis of colorectal cancer through Wnt/β-catenin signaling |
| Q37074078 | Obesity promotes PhIP-induced small intestinal carcinogenesis in hCYP1A-db/db mice: involvement of mutations and DNA hypermethylation of Apc. |
| Q37854803 | Obesity‐related colon cancer: Dietary factors and their mechanisms of anticancer action‡ |
| Q37325202 | Olfactomedin 4 deletion induces colon adenocarcinoma in Apc(Min/+) mice |
| Q34459046 | Omega-3 fatty acid is a potential preventive agent for recurrent colon cancer |
| Q27003364 | On the apparent rarity of epithelial cancers in captive chimpanzees |
| Q33694667 | Oncogenic mutations in intestinal adenomas regulate Bim-mediated apoptosis induced by TGF-β |
| Q44943773 | Oncogenic β-catenin and PIK3CA instruct network states and cancer phenotypes in intestinal organoids. |
| Q50648214 | Oncogenicity of LHX4 in colorectal cancer through Wnt/β-catenin/TCF4 cascade |
| Q33765195 | Optimization of a pentaplex panel for MSI analysis without control DNA in a Brazilian population: correlation with ancestry markers. |
| Q48120325 | Oral delivery of siRNA lipid nanoparticles: Fate in the GI tract |
| Q99636824 | Organoid Models of Colorectal Pathology: Do They Hold the Key to Personalized Medicine? A Systematic Review |
| Q35649789 | Ovarian stem cells: From basic to clinical applications |
| Q51383263 | Ovarian steroid cell tumor with biallelic adenomatous polyposis coli inactivation in a patient with familial adenomatous polyposis. |
| Q61632631 | Overcoming Drug Resistance in Colorectal Cancer by MicroRNAs |
| Q51118852 | Overexpression of Hepatocyte Cell Adhesion Molecule (hepaCAM) Inhibits the Proliferation, Migration, and Invasion in Colorectal Cancer Cells |
| Q51650705 | Overproduction of IGF-2 drives a subset of colorectal cancer cells, which specifically respond to an anti-IGF therapeutic antibody and combination therapies |
| Q35173907 | P53 mutations occur more commonly than KRAS mutations in colorectal adenoma |
| Q37745350 | PI3K/AKT-mediated upregulation of WDR5 promotes colorectal cancer metastasis by directly targeting ZNF407. |
| Q41709327 | PPA1 regulates tumor malignant potential and clinical outcome of colon adenocarcinoma through JNK pathways |
| Q36546764 | PRIMA-1met (APR-246) inhibits growth of colorectal cancer cells with different p53 status through distinct mechanisms |
| Q36621295 | PS341 inhibits hepatocellular and colorectal cancer cells through the FOXO3/CTNNB1 signaling pathway |
| Q55344912 | PTPRS Regulates Colorectal Cancer RAS Pathway Activity by Inactivating Erk and Preventing Its Nuclear Translocation. |
| Q34786561 | Paradoxical role of CBX8 in proliferation and metastasis of colorectal cancer |
| Q43696219 | Pathogenesis of microsatellite-unstable colorectal cancer. Evaluation of new diagnostic and therapeutic options |
| Q26991908 | Personalised cancer medicine |
| Q38363276 | Personalized treatment for colorectal cancer: novel developments and putative therapeutic strategies |
| Q37962026 | Pharmacology and cellular/molecular mechanisms of action of aspirin and Non-aspirin NSAIDs in colorectal cancer |
| Q35721747 | Phosphatase and Tensin Homolog (PTEN) Represses Colon Cancer Progression through Inhibiting Paxillin Transcription via PI3K/AKT/NF-κB Pathway |
| Q49787846 | Phospholipase Cγ1 links inflammation and tumorigenesis in colitis-associated cancer |
| Q42376377 | Pien Tze Huang inhibits the proliferation of colorectal cancer cells by increasing the expression of miR-34c-5p |
| Q37548804 | Plasma YKL-40 in patients with metastatic colorectal cancer treated with first line oxaliplatin-based regimen with or without cetuximab: RESULTS from the NORDIC VII Study |
| Q37513254 | Potential tumor-suppressive role of monoglyceride lipase in human colorectal cancer |
| Q36363009 | Powerful Set-Based Gene-Environment Interaction Testing Framework for Complex Diseases |
| Q35800325 | Precritical State Transition Dynamics in the Attractor Landscape of a Molecular Interaction Network Underlying Colorectal Tumorigenesis |
| Q93198699 | Prevalence and characteristics of PIK3CA mutation in mismatch repair-deficient colorectal cancer |
| Q84058811 | Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study |
| Q33754774 | Prevention of Colorectal Cancer by Targeting Obesity-Related Disorders and Inflammation |
| Q37630186 | Proactive strategies for regorafenib in metastatic colorectal cancer: implications for optimal patient management. |
| Q33659798 | Prognostic Significance of β-Catenin, E-Cadherin, and SOX9 in Colorectal Cancer: Results from a Large Population-Representative Series |
| Q35138892 | Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer |
| Q34762217 | Promoter methylation of tumor suppressor genes in pre-neoplastic lesions; potential marker of disease recurrence. |
| Q38877277 | Prospective derivation of a living organoid biobank of colorectal cancer patients. |
| Q36579336 | Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis |
| Q30414232 | Prostate cancer induced by loss of Apc is restrained by TGFβ signaling |
| Q28244320 | Proteogenomic characterization of human colon and rectal cancer |
| Q39439499 | Proteomic consequences of a single gene mutation in a colorectal cancer model |
| Q34454877 | Proteomic workflow for analysis of archival formalin‐fixed and paraffin‐embedded clinical samples to a depth of 10 000 proteins |
| Q47340368 | Proximal Aberrant Crypt Foci Associate with Synchronous Neoplasia and are Primed for Neoplastic Progression |
| Q46266548 | Pteisolic acid G, a novel ent-kaurane diterpenoid, inhibits viability and induces apoptosis in human colorectal carcinoma cells |
| Q35859573 | Quantitative Profiling of Protein Tyrosine Kinases in Human Cancer Cell Lines by Multiplexed Parallel Reaction Monitoring Assays |
| Q38116869 | RAS signaling pathways, mutations and their role in colorectal cancer |
| Q125637295 | RETRACTED ARTICLE: Long non-coding RNA DCST1-AS1/hsa-miR-582-5p/HMGB1 axis regulates colorectal cancer progression |
| Q37566592 | RNA virus receptor Rig-I monitors gut microbiota and inhibits colitis-associated colorectal cancer |
| Q38630685 | RNF183 promotes proliferation and metastasis of colorectal cancer cells via activation of NF-κB-IL-8 axis |
| Q37113219 | ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration |
| Q28396460 | ROS, Notch, and Wnt signaling pathways: crosstalk between three major regulators of cardiovascular biology |
| Q47156095 | RRS1 silencing suppresses colorectal cancer cell proliferation and tumorigenesis by inhibiting G2/M progression and angiogenesis |
| Q28075465 | Racial disparity in colorectal cancer: Gut microbiome and cancer stem cells |
| Q38764759 | Rad51C-ATXN7 fusion gene expression in colorectal tumors |
| Q54517954 | Ras Stabilization Through Aberrant Activation of Wnt/β-Catenin Signaling Promotes Intestinal Tumorigenesis |
| Q52721338 | Ras and Rap1: A tale of two GTPases. |
| Q35052477 | Real-time imaging of myeloid cells dynamics in ApcMin/+ intestinal tumors by spinning disk confocal microscopy |
| Q36949683 | Recurrent R-spondin fusions in colon cancer |
| Q37972816 | Red meat consumption and cancer: Reasons to suspect involvement of bovine infectious factors in colorectal cancer |
| Q91705167 | Reduced microRNA 375 in colorectal cancer upregulates metadherin-mediated signaling |
| Q28603875 | Registered report: Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma |
| Q90225694 | Regulation of Ketogenic Enzyme HMGCS2 by Wnt/β-catenin/PPARγ Pathway in Intestinal Cells |
| Q85739124 | Regulation of MLH1 mRNA and protein expression by promoter methylation in primary colorectal cancer: a descriptive and prognostic cancer marker study |
| Q26775423 | Regulation of MYC gene expression by aberrant Wnt/β-catenin signaling in colorectal cancer |
| Q36860267 | Regulation of Wnt4 in chronic obstructive pulmonary disease |
| Q36418722 | Relationship between Preoperative ¹⁸F-Fluorodeoxyglucose Uptake and Epidermal Growth Factor Receptor Status in Primary Colorectal Cancer. |
| Q34463139 | Republished: tracing PAKs from GI inflammation to cancer |
| Q39191677 | Retracted: Role of STAT3 and vitamin D receptor in EZH2‐mediated invasion of human colorectal cancer |
| Q93161855 | Retrotransposon insertions can initiate colorectal cancer and are associated with poor survival |
| Q48208216 | Reversal of hyperactive Wnt signaling-dependent adipocyte defects by peptide boronic acids. |
| Q93066429 | Reviewing the role of P2Y receptors in specific gastrointestinal cancers |
| Q91949803 | Right and left-sided colon cancers - specificity of molecular mechanisms in tumorigenesis and progression |
| Q49237718 | Rimonabant Kills Colon Cancer Stem Cells without Inducing Toxicity in Normal Colon Organoids |
| Q37313245 | Role of S100A3 in human colorectal cancer and the anticancer effect of cantharidinate |
| Q58128147 | Role of curcumin in preventing familial adenomatous polyposis |
| Q37267725 | SEPT9 and SHOX2 DNA methylation status and its utility in the diagnosis of colonic adenomas and colorectal adenocarcinomas |
| Q39211407 | SLIT2 inhibits cell migration in colorectal cancer through the AKT–GSK3β signaling pathway |
| Q34486808 | Screening of Finnish RAD51C founder mutations in prostate and colorectal cancer patients |
| Q35169992 | Secernin-1 contributes to colon cancer progression through enhancing matrix metalloproteinase-2/9 exocytosis |
| Q64101631 | Selected Aspects of Chemoresistance Mechanisms in Colorectal Carcinoma-A Focus on Epithelial-to-Mesenchymal Transition, Autophagy, and Apoptosis |
| Q52423597 | Sequential cancer mutations in cultured human intestinal stem cells |
| Q26751035 | Serrated colorectal cancer: Molecular classification, prognosis, and response to chemotherapy |
| Q27010553 | Serrated pathway in colorectal carcinogenesis |
| Q28264306 | Signal Transducer and Activator of Transcription 3 (STAT3) Protein Suppresses Adenoma-to-carcinoma Transition in Apc/+ Mice via Regulation of Snail-1 (SNAI) Protein Stability |
| Q101133262 | Signal transduction pathway mutations in gastrointestinal (GI) cancers: a systematic review and meta-analysis |
| Q91897235 | Signaling pathways involved in colorectal cancer progression |
| Q26795609 | Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance |
| Q30912170 | Simultaneous inference of cancer pathways and tumor progression from cross-sectional mutation data |
| Q61807849 | Sine oculis homeobox 1 promotes proliferation and migration of human colorectal cancer cells through activation of Wnt/β-catenin signaling |
| Q31133433 | Single-cell SNP analyses and interpretations based on RNA-Seq data for colon cancer research |
| Q37955579 | Sleeping Beauty – A mouse model for all cancers? |
| Q91742165 | Smad7 and Colorectal Carcinogenesis: A Double-Edged Sword |
| Q33878967 | Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer |
| Q36050149 | Small-molecule binding of the axin RGS domain promotes β-catenin and Ras degradation |
| Q52336141 | Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune response. |
| Q36580560 | Somatic rearrangements across cancer reveal classes of samples with distinct patterns of DNA breakage and rearrangement-induced hypermutability |
| Q37062872 | Sox9 induction, ectopic Paneth cells, and mitotic spindle axis defects in mouse colon adenomatous epithelium arising from conditional biallelic Apc inactivation |
| Q33581581 | Specific microRNA-mRNA Regulatory Network of Colon Cancer Invasion Mediated by Tissue Kallikrein-Related Peptidase 6. |
| Q39139086 | Specific mutations in KRAS codon 12 are associated with worse overall survival in patients with advanced and recurrent colorectal cancer |
| Q61796403 | Sphere‑forming assay vs. organoid culture: Determining long‑term stemness and the chemoresistant capacity of primary colorectal cancer cells |
| Q55212706 | Stearoyl-CoA desaturase-1 promotes colorectal cancer metastasis in response to glucose by suppressing PTEN. |
| Q28076017 | Stem cell dynamics and pretumor progression in the intestinal tract |
| Q38219625 | Stem cell dynamics in homeostasis and cancer of the intestine |
| Q55667339 | Stepwise approach to SNP-set analysis illustrated with the Metabochip and colorectal cancer in Japanese Americans of the Multiethnic Cohort. |
| Q34396677 | Structural, functional and molecular analysis of the effects of aging in the small intestine and colon of C57BL/6J mice |
| Q34526671 | Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines |
| Q53615706 | Surgical treatment of multiple sporadic colorectal carcinoma |
| Q27013718 | Survivin and angiotensin-converting enzyme polymorphisms with risk of colorectal cancer: a systematic review and meta-analysis |
| Q90352739 | Synaptotagmin7 Is Overexpressed In Colorectal Cancer And Regulates Colorectal Cancer Cell Proliferation |
| Q60937768 | Synthetic Cannabinoid Activity Against Colorectal Cancer Cells |
| Q40114381 | Synthetic lethal short hairpin RNA screening reveals that ring finger protein 183 confers resistance to trametinib in colorectal cancer cells |
| Q101574338 | Synthetic lethality between MyD88 loss and mutations in Wnt/β-catenin pathway in intestinal tumor epithelial cells |
| Q35059602 | Systematic genomic identification of colorectal cancer genes delineating advanced from early clinical stage and metastasis |
| Q35763436 | Systems-wide RNAi analysis of CASP8AP2/FLASH shows transcriptional deregulation of the replication-dependent histone genes and extensive effects on the transcriptome of colorectal cancer cells. |
| Q37702574 | T lymphocyte SHP2-deficiency triggers anti-tumor immunity to inhibit colitis-associated cancer in mice |
| Q88702138 | TIGAR knockdown enhanced the anticancer effect of aescin via regulating autophagy and apoptosis in colorectal cancer cells |
| Q92807356 | TRPM4 is highly expressed in human colorectal tumor buds and contributes to proliferation, cell cycle, and invasion of colorectal cancer cells |
| Q92835171 | Targeted molecular profiling of genetic alterations in colorectal cancer using next-generation sequencing |
| Q28655517 | Targeted repression of AXIN2 and MYC gene expression using designer TALEs |
| Q34735416 | Targeted sequencing of cancer-related genes in colorectal cancer using next-generation sequencing |
| Q36646911 | Targeted therapies in colorectal cancer—an integrative view by PPPM |
| Q39441327 | Targeting TGF-β Signaling in Cancer |
| Q90020207 | Targeting Wnt Signaling via Notch in Intestinal Carcinogenesis |
| Q38569786 | Targeting Wnt signaling in colorectal cancer. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanisms |
| Q27027266 | Targeting aberrant colon cancer-specific DNA methylation with lipoteichoic acid-deficient Lactobacillus acidophilus |
| Q36356078 | Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3 |
| Q42357549 | Targeting protein tyrosine kinase 6 enhances apoptosis of colon cancer cells following DNA damage |
| Q39456735 | Targeting the Microenvironment in Advanced Colorectal Cancer |
| Q42133560 | Targeting tumor multicellular aggregation through IGPR-1 inhibits colon cancer growth and improves chemotherapy. |
| Q55260595 | Teaming Up for Trouble: Cancer Cells, Transforming Growth Factor-β1 Signaling and the Epigenetic Corruption of Stromal Naïve Fibroblasts. |
| Q51598791 | Tescalcin expression contributes to invasive and metastatic activity in colorectal cancer |
| Q52571294 | Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas. |
| Q95642199 | The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives |
| Q37908119 | The Causes and Consequences of Polyploidy in Normal Development and Cancer |
| Q39133310 | The Contributions of Human Mini-Intestines to the Study of Intestinal Physiology and Pathophysiology |
| Q41991370 | The ESRP1-GPR137 axis contributes to intestinal pathogenesis. |
| Q58798789 | The Guanylate Cyclase C-cGMP Signaling Axis Opposes Intestinal Epithelial Injury and Neoplasia |
| Q36597522 | The IL-33/ST2 pathway contributes to intestinal tumorigenesis in humans and mice |
| Q92971247 | The Intestinal Stem Cell Niche: A Central Role for Foxl1-Expressing Subepithelial Telocytes |
| Q36937205 | The MYC 3' Wnt-Responsive Element Drives Oncogenic MYC Expression in Human Colorectal Cancer Cells |
| Q33823452 | The NF1 somatic mutational landscape in sporadic human cancers |
| Q92264981 | The Novel Small-Molecule SR18662 Efficiently Inhibits the Growth of Colorectal Cancer In Vitro and In Vivo |
| Q54276735 | The Proto-Oncogene KRAS and BRAF Profiles and Some Clinical Characteristics in Colorectal Cancer in the Turkish Population |
| Q37571181 | The Role of IL-33-Dependent Inflammation in the Tumor Microenvironment. |
| Q32183705 | The Role of Somatic L1 Retrotransposition in Human Cancers |
| Q38893314 | The Role of Stem Cell DNA Methylation in Colorectal Carcinogenesis |
| Q26741388 | The Role of the C-Clamp in Wnt-Related Colorectal Cancers |
| Q30437998 | The Theranostic Path to Personalized Nanomedicine |
| Q37116458 | The attitudes of people with sarcoma and their family towards genomics and incidental information arising from genetic research |
| Q44619316 | The burden of faulty proofreading in colon cancer |
| Q37699177 | The chromatin-remodeling enzyme BRG1 promotes colon cancer progression via positive regulation of WNT3A. |
| Q90259673 | The controversial role of Enterococcus faecalis in colorectal cancer |
| Q52665387 | The cytotoxic, apoptotic and oxidative effects of carbonic anhydrase IX inhibitor on colorectal cancer cells. |
| Q33905852 | The essential role of TAp73 in bortezomib-induced apoptosis in p53-deficient colorectal cancer cells |
| Q21090644 | The expression and prognostic significance of retinoic acid metabolising enzymes in colorectal cancer |
| Q28077234 | The genetic heterogeneity of colorectal cancer predisposition - guidelines for gene discovery |
| Q64275763 | The histone H3 lysine-27 demethylase UTX plays a critical role in colorectal cancer cell proliferation |
| Q47634731 | The human PKP2/plakophilin-2 gene is induced by Wnt/β-catenin in normal and colon cancer-associated fibroblasts |
| Q34457985 | The human gut microbiome as a screening tool for colorectal cancer. |
| Q47418712 | The impact of primary tumor location in patients with metastatic colorectal cancer: a Korean Cancer Study Group CO12-04 study |
| Q90003187 | The influence of blood on the human gut microbiome |
| Q35249997 | The intrauterine and nursing period is a window of susceptibility for development of obesity and intestinal tumorigenesis by a high fat diet in Min/+ mice as adults |
| Q37713641 | The myc 3' wnt-responsive element suppresses colonic tumorigenesis |
| Q54297427 | The utility of diagnostic biopsy specimens for predictive molecular testing in colorectal cancer |
| Q28071309 | Therapeutic aspects of c-MYC signaling in inflammatory and cancerous colonic diseases |
| Q36036531 | Time-serial Assessment of Drug Combination Interventions in a Mouse Model of Colorectal Carcinogenesis Using Optical Coherence Tomography |
| Q92462964 | Tissue of origin dictates GOT1 dependence and confers synthetic lethality to radiotherapy |
| Q35830331 | Tissue-Specific Effects of Reduced β-catenin Expression on Adenomatous Polyposis Coli Mutation-Instigated Tumorigenesis in Mouse Colon and Ovarian Epithelium |
| Q40555695 | Tissue-specific mutation accumulation in human adult stem cells during life |
| Q37445275 | Toward a comprehensive and systematic methylome signature in colorectal cancers |
| Q38113960 | Towards a vaccine to prevent cancer in Lynch syndrome patients |
| Q38041096 | Transcriptional networks in liver and intestinal development |
| Q50642659 | Transgenic expression of oncogenic BRAF induces loss of stem cells in the mouse intestine, which is antagonized by β-catenin activity |
| Q42530938 | Transition from colitis to cancer: high Wnt activity sustains the tumor-initiating potential of colon cancer stem cell precursors |
| Q33722761 | Translating colorectal cancer prevention through the guanylyl cyclase C signaling axis |
| Q26776215 | Treatment Individualization in Colorectal Cancer |
| Q92427915 | Trp53 null and R270H mutant alleles have comparable effects in regulating invasion, metastasis, and gene expression in mouse colon tumorigenesis |
| Q36723450 | Tumor suppressive role of sestrin2 during colitis and colon carcinogenesis. |
| Q39194701 | Tumor suppressor genes in familial adenomatous polyposis |
| Q46238868 | Tumor-derived exosomes in colorectal cancer progression and their clinical applications |
| Q36757322 | Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1 |
| Q92130522 | Uncovering Potential Therapeutic Targets in Colorectal Cancer by Deciphering Mutational Status and Expression of Druggable Oncogenes |
| Q39090006 | Up-regulation of tripartite motif-containing 29 promotes cancer cell proliferation and predicts poor survival in colorectal cancer |
| Q54979868 | Update on Sporadic Colorectal Cancer Genetics. |
| Q58697697 | Vitamin C promotes decitabine or azacytidine induced DNA hydroxymethylation and subsequent reactivation of the epigenetically silenced tumour suppressor in colon cancer cells |
| Q33758617 | Vitamin D/VDR, Probiotics, and Gastrointestinal Diseases |
| Q35600360 | Volatility of Mutator Phenotypes at Single Cell Resolution |
| Q37701641 | Whole-exome sequencing identified mutational profiles of high-grade colon adenomas |
| Q33791204 | Wiring miRNAs to pathways: a topological approach to integrate miRNA and mRNA expression profiles |
| Q26746101 | Wnt Signaling in Cancer Stem Cell Biology |
| Q40191438 | Wnt is necessary for mesenchymal to epithelial transition in colorectal cancer cells. |
| Q42321100 | Wnt signalling is a bi-directional vulnerability of cancer cells |
| Q42034441 | YAP-IL-6ST autoregulatory loop activated on APC loss controls colonic tumorigenesis |
| Q35674089 | cir-ITCH plays an inhibitory role in colorectal cancer by regulating the Wnt/β-catenin pathway |
| Q35616117 | dNTP pool levels modulate mutator phenotypes of error-prone DNA polymerase ε variants |
| Q52945589 | miR-107 Promotes Proliferation and Inhibits Apoptosis of Colon Cancer Cells by Targeting Prostate Apoptosis Response-4 (Par4). |
| Q45839379 | miR-187 inhibits the growth of cervical cancer cells by targeting FGF9. |
| Q36837231 | miR-23a promotes the transition from indolent to invasive colorectal cancer |
| Q47148750 | miR-449a inhibits colorectal cancer progression by targeting SATB2. |
| Q41701952 | miRNA biogenesis-associated RNase III nucleases Drosha and Dicer are upregulated in colorectal adenocarcinoma |
| Q98652622 | α-Ketoglutarate attenuates Wnt signaling and drives differentiation in colorectal cancer |
| Q49547317 | β-Catenin mRNA Silencing and MEK Inhibition Display Synergistic Efficacy in Preclinical Tumor Models |
| Q91746684 | β-Catenin/TCF4 Complex-Mediated Induction of the NRF3 (NFE2L3) Gene in Cancer Cells |
| Q49750144 | β-catenin, leucine-rich repeat-containing G protein-coupled receptor 5 and GATA-binding factor 6 are associated with the normal mucosa-adenoma-adenocarcinoma sequence of colorectal tumorigenesis |
Search more.